HCM
CLB icon

Howland Capital Management’s Core Laboratories CLB Stock Holding History

Howland Capital Management’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-15,375
Closed -$159K – 213
2020
Q1 		$159K Sell
15,375
-15,741
-51% -$440K 0.01% 192
2019
Q4 		$1.17M Buy
31,116
+4,600
+17% +$207K 0.08% 107
2019
Q3 		$1.24M Sell
26,516
-23,625
-47% -$1.1M 0.09% 106
2019
Q2 		$2.62M Sell
50,141
-10,707
-18% -$628K 0.2% 78
2019
Q1 		$4.19M Sell
60,848
-26,742
-31% -$1.79M 0.34% 66
2018
Q4 		$5.23M Sell
87,590
-25,275
-22% -$2.18M 0.49% 62
2018
Q3 		$13.1M Buy
112,865
+2,762
+3% +$312K 0.99% 38
2018
Q2 		$13.9M Buy
110,103
+420
+0.4% +$51.1K 1.11% 33
2018
Q1 		$11.9M Buy
109,683
+6,518
+6% +$721K 0.96% 42
2017
Q4 		$11.3M Sell
103,165
-2,486
-2% -$248K 0.9% 47
2017
Q3 		$10.4M Sell
105,651
-1,223
-1% -$119K 0.86% 48
2017
Q2 		$10.8M Buy
106,874
+883
+0.8% +$95.2K 0.92% 46
2017
Q1 		$12.2M Buy
105,991
+4,367
+4% +$508K 1.06% 40
2016
Q4 		$12.2M Sell
101,624
-6,775
-6% -$750K 1.14% 39
2016
Q3 		$12.2M Buy
108,399
+3,970
+4% +$457K 1.13% 37
2016
Q2 		$12.9M Buy
104,429
+374
+0.4% +$45.1K 1.22% 35
2016
Q1 		$11.7M Buy
104,055
+1,985
+2% +$206K 1.19% 35
2015
Q4 		$11.1M Buy
102,070
+4,562
+5% +$522K 1.13% 39
2015
Q3 		$9.73M Buy
97,508
+369
+0.4% +$40.1K 1.06% 40
2015
Q2 		$11.1M Buy
97,139
+8
+0% +$970 1.14% 40
2015
Q1 		$10.1M Buy
97,131
+2,840
+3% +$303K 1.03% 41
2014
Q4 		$11.3M Buy
94,291
+6,584
+8% +$865K 1.13% 40
2014
Q3 		$12.8M Buy
87,707
+3,531
+4% +$545K 1.32% 34
2014
Q2 		$14.1M Buy
84,176
+9,844
+13% +$1.75M 1.44% 25
2014
Q1 		$14.8M Buy
74,332
+5,308
+8% +$1M 1.67% 15
2013
Q4 		$13.2M Sell
69,024
-13,130
-16% -$2.44M 1.64% 16
2013
Q3 		$13.9M Buy
82,154
+175
+0.2% +$27.2K 1.89% 10
2013
Q2 		$12.4M Buy
+81,979
New +$11.6M 1.96% 10

Other funds holding CLB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
AC
AKO Capital London, United Kingdom $4.29B AUM 4.26% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return

Howland Capital Management's CLB Position: Q2 2020 in Review

Howland Capital Management sold out of Core Laboratories (CLB) in Q2 2020, closing a stake of 15,375 shares — an estimated $159K sold.

Howland Capital Management first reported a position in CLB in Q2 2013 and held it in 28 quarters. The position peaked at $14.8M in Q1 2014. 197 funds tracked by Wall St. Rank hold CLB as of Q2 2020.

  • Howland Capital Management reported no remaining Core Laboratories position as of Q2 2020 after selling out during the quarter.
  • Howland Capital Management sold 15,375 Core Laboratories shares in Q2 2020, an estimated $159K.
  • Howland Capital Management first reported a position in Core Laboratories in Q2 2013 and held it in 28 quarters.
  • Howland Capital Management's Core Laboratories position peaked at $14.8M in Q1 2014.
  • 197 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2020.

Based on Howland Capital Management's 13F filing for Q2 2020, filed 15 Jul 2020.